Category: Sweden

Yearly Life Sciences Reports of Sweden

Swedish Life Sciences Trend Analysis 2017

2017 was another very quiet year in Sweden. The downward trend from 2016 continued and only very few new Biotech companies were founded. Accordingly, a significant drop in the Biotech – and Life Science Venture Financing could be seen with a low number of overall financing rounds. Please click on the link below for the … Continue reading Swedish Life Sciences Trend Analysis 2017

Read more

Swedish Life Sciences Trend Analysis 2016

In 2015 we saw a continuation of the downward trend when it comes to the number of new Biotech companies in Sweden. Also, the value of venture funds invested in the industry dropped dramatically and was about seven times smaller than in 2014. It changed, however, in the first half of 2016, when Aprea Ab … Continue reading Swedish Life Sciences Trend Analysis 2016

Read more

Sweden Life Sciences Trend Analysis 2015

After the best venture financing of Swedish Biotechnology Company of the last 5 years in 2014, the venture financing goes back to previous level in 2015 to date. The pipeline is maturing and renewing at the same time, with the number of products in phase II similar to the number of product in preclinical studies. … Continue reading Sweden Life Sciences Trend Analysis 2015

Read more

Swedish Life Sciences Trend Analysis 2014

2013 saw the Swedish Biotech Industry raising a significantly smaller venture financing amount than in the year before (USD 27m compared to USD 127m in 2012). During the same period the number of companies achieving an IPO exit doubled. The number of biotech products in Phase I of development remained stable compared to last year, … Continue reading Swedish Life Sciences Trend Analysis 2014

Read more